Recombinant Human Granulocyte Macrophage Colony Stimulating Factor

Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (rHu GM-CSF) is produced in response to a number of inflammatory mediators by mesenchymal cells present in the hemopoietic environment and at peripheral sites of inflammation.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Akron Biotech
Recombinant Human Granulocyte Macrophage Colony StimulatingFactor (rHu GM-CSF) is produced in response to a number of inflammatorymediators by mesenchymal cells present in the hemopoietic environment and atperipheral sites of inflammation. GM-CSF is able to stimulate the production ofneutrophilic granulocytes, macrophages, and mixed granulocyte-macrophagecolonies from bone marrow cells and can stimulate the formation of eosinophilcolonies from fetal liver progenitor cells. GM-CSF can also stimulate somefunctional activities in mature granulocytes and macrophages. rHu GM-CSFreceptors show significant homologies with other receptors for hematopoieticgrowth factors, including IL2-beta, IL-3, IL-6, IL-7, EPO and the Prolactinreceptors. rHu GM-CSF produced in E. coli is a single, non-glycosylated,polypeptide chain that contains 127 amino acids and has a molecular mass of14.48 kDa. The product is very stable for up to three years from manufacturingdate, when stored lyophilized at -20° C.
Akron Biotech
(561) 750-6120
www.akronbiotech.com

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue